Liquid biopsy: state of reproductive medicine and beyond

Hum Reprod. 2021 Oct 18;36(11):2824-2839. doi: 10.1093/humrep/deab206.

Abstract

Liquid biopsy is the process of sampling and analyzing body fluids, which enables non-invasive monitoring of complex biological systems in vivo. Liquid biopsy has myriad applications in health and disease as a wide variety of components, ranging from circulating cells to cell-free nucleic acid molecules, can be analyzed. Here, we review different components of liquid biopsy, survey state-of-the-art, non-invasive methods for detecting those components, demonstrate their clinical applications and discuss ethical considerations. Furthermore, we emphasize the importance of artificial intelligence in analyzing liquid biopsy data with the aim of developing ethically-responsible non-invasive technologies that can enhance individualized healthcare. While previous reviews have mainly focused on cancer, this review primarily highlights applications of liquid biopsy in reproductive medicine.

Keywords: ART; IVF; artificial intelligence; cell-free DNA; circulating cells; liquid biopsy; next generation sequencing; non-invasive prenatal testing; preimplantation genetic testing; spent embryo culture medium.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Artificial Intelligence
  • Biomarkers, Tumor
  • Biopsy
  • Cell-Free Nucleic Acids*
  • Humans
  • Liquid Biopsy
  • Neoplasms*
  • Reproductive Medicine*

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids